Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Nanosonics Limited ( (AU:NAN) ) has provided an update.
Nanosonics Limited responded to a query from the Australian Securities Exchange (ASX) regarding unusual trading activity in its securities. The company stated that it is not aware of any undisclosed information that could explain the recent price and volume changes and confirmed compliance with ASX Listing Rules, particularly Rule 3.1, which pertains to continuous disclosure obligations.
The most recent analyst rating on (AU:NAN) stock is a Sell with a A$4.00 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is a company operating in the medical technology industry, primarily focused on infection prevention solutions. The company’s flagship product is the trophon® EPR, a device for high-level disinfection of ultrasound probes, which positions it as a leader in the healthcare market for infection control.
Average Trading Volume: 1,080,725
Technical Sentiment Signal: Buy
Current Market Cap: A$1.47B
For an in-depth examination of NAN stock, go to TipRanks’ Stock Analysis page.